# Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage

> **NCT06999785** · NA · RECRUITING · sponsor: **University Hospital, Angers** · enrollment: 60 (estimated)

## Conditions studied

- Hyperbaric Oxygen
- Genotoxicity
- Malignancy

## Interventions

- **BIOLOGICAL:** Blood test

## Key facts

- **NCT ID:** NCT06999785
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-08
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-11-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06999785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06999785, "Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06999785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*